High Eradication Rates of Helicobacter pylori Infection Following Sequential Therapy: The Israeli Experience Treating Naïve Patients

Helicobacter

Volumn 16, Issue 3, 2011, Pages 229-233

  Schmiloviz Weiss, Hemda ^a   Shalev, Tamar ^a   Chechoulin, Yelena ^a   Levi, Zohar ^a   Yishai, Ron ^a   Sehayek Shabbat, Vered ^a   Niv, Yaron ^a   Shirin, Haim ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Eradication rates; Helicobacter pylori; Sequential therapy

Indexed keywords

AMOXICILLIN; CARBON 13; CLARITHROMYCIN; OMEPRAZOLE; TINIDAZOLE; UREASE;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG DOSE SEQUENCE; DRUG EFFICACY; ERADICATION THERAPY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HEADACHE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTENTION TO TREAT ANALYSIS; ISRAEL; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; TASTE DISORDER; TREATMENT DURATION; TREATMENT INDICATION; UREA BREATH TEST;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ISRAEL; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; TINIDAZOLE; TREATMENT OUTCOME;

HELICOBACTER PYLORI;

EID: 79956084995     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2011.00834.x     Document Type: Article

References (34)

1. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
2. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;99(Suppl 2):45-51.
3. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes, and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
4. Bertoni G, Sassatelli R, Nigrisoli E, Tansini P, Bianchi G, Della Casa G, Bagni A, Bedogni G. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol 1996;91:258-63.
5. O'Connor A, Gisbert J, O'Morain C. Treatment of Helicobacter infection. Helicobacter 2009;14(Suppl 1):46-51.
6. 13C-urea breath test, referral patterns, and results in children. J Clin Gastroenterol 2003;37:142-6.
7. O'Connor A, Taneike I, Nami A, Fitzgerald N, Murphy P, Ryan B, O'Connor H, Qasim A, Breslin N, O'Moráin C. Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland. Eur J Gastroenterol Hepatol 2010;22:1123-7.
8. Raymond J, Lamarque D, Kalach N, Chaussade S, Burucoa C. High level of antimicrobial resistance in French Helicobacter pylori isolates. Helicobacter 2010;15:21-7.
9. Agudo S, Alarcón T, Cibrelus L, Urruzuno P, Martinez MJ, Lopez-Brea M. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children. Rev Esp Quimioter 2009;22:88-92.
10. Boyanova L. Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria. J Med Microbiol 2009;58:930-5.
11. Horiki N, Omata F, Uemura M, et al. Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. Helicobacter 2009;14:86-90.
12. Avidan B, Weiss B, Chowers Y, Younash A, Bar-Meir S, Keler N. Sensitivity and resistance of Helicobacter pylori to antibiotic treatment. Harefuah 1999;137:272-4.
13. Samra Z, Shmuely H, Niv Y, Dinari G, Passaro DJ, Geler A, Gal E, Fishman M, Bachor J, Yahav J. Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime. J Antimicrob Chemother 2002;49:1023-6.
14. Faber J, Bar-Meir M, Rudensky B, Schlesinger Y, Rachman E, Benenson S, Sirota G, Stankiewic H, Halle D, Wilschanski M. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful? J Pediatr Gastroenterol Nutr 2005;40:571-4.
15. Zevit N, Levy I, Shmuely H, Samra Z, Yahav J. Antibiotic resistance of Helicobacter pylori in Israeli children. Scand J Gastroenterol 2010;45:550-5.
16. Yahav J, Shmuely H, Niv Y, Bechor J, Samra Z. In vitro activity of levofloxacin against Helicobacter pylori isolates from patients after treatment failure. Diagn Microbiol Infect Dis 2006;55:81-3.
17. De Francesco V, Giorgio F, Hassan C, et al. Worldwide H. pylori antibiotic resistance: a systemic review. J Gastrointestin Liver Dis 2010;19:409-14.
18. Zullo A, Rinaldi V, Winn S, Meddi P, Lionetti R, Hassan C, Ripani C, Tomaselli G, Attili AF. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000;14:715-8.
19. Zullo A, Vaira D, Vakil N, et al. High eradication rates of Helicobacter pylori with a new a sequential treatment. Aliment Pharmacol Ther 2003;17:719-26.
20. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regimen for Helicobacter pylori eradication: a pooled data analysis. Gut 2007;56:1353-7.
21. Jafri NS, Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naïve to treatment. Ann Intern Med 2008;148:923-31.
22. Gatta L, Vakil N, Leandro G, Di Mario F, Vaira D. Sequential therapy or triple therapy for Helicobacter pylori infection: systemic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol 2009;104:3069-79.
23. Chey WD, Wong BC, Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-25.
24. Fock KM, Katelaris P, Sugano K, et al. Second Asia-Pacific consensus guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009;24:1587-600.
25. Graham DY, Osato MS, Hoffman J, Opekun AR, Anderson SY, El-Zimaity HM. Furazolidone combination therapies for Helicobacter pylori infection in the United States. Aliment Pharmacol Ther 2000;14:211-5.
26. Moshkowitz M, Konikoff FM, Peled Y, Brill S, Hallak A, Tiomny E, Santo M, Bujanover Y, Gilat T. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. Aliment Pharmacol Ther 1996;10:1015-9.
27. 13C-urea breath test to validate eradication of Helicobacter pylori in an Israeli population. Isr Med Assoc J 2003;5:98-100.
28. Levine A, Milo T, Broide E, Wine E, Dalal I, Boaz M, Avni Y, Shirin H. Influence of Helicobacter pylori eradication on gastroesophageal reflux symptoms and epigastric pain in children and adolescents. Pediatrics 2004;113:54-5.
29. Niv Y. Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication. Dig Dis Sci 2005;50:839-41.
30. Niv Y, Koren R. 13C-urea breath test for success of Helicobacter pylori eradication: study of 5885 Israeli patients. Dig Dis Sci 2005;50:1513-6.
31. 13C urea breath test. Digestion 2005;71:208-12.
32. Shmuely H, Yahav J, Samra Z, Chodick G, Koren R, Niv Y, Ofek I. Effect of cranberry juice on eradication of Helicobacter pylori in patients treated with antibiotics and a proton pump inhibitor. Mol Nutr Food Res 2007;51:746-51.
33. Tong JL, Ran ZH, Shen J, Xiao SD. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis. J Clin Pharm Ther 2009;43:41-53.
34. Gisbert JP, Calvet X, O'Connor A, Megraud F, O'Morain CA. Sequential therapy for Helicobacter pylori eradication: a critical review. J Clin Gastroenterol 2010;44:313-25.